Medscape18h
Blood Test Unveils Disease Course in Limited Cutaneous Systemic Sclerosis
Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...
Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZ®
Breckenridge Pharmaceutical, Inc., -the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, - announced today that the Food and ...
Pharm Exec14d
FDA Approves Two Generics from Amneal Pharmaceuticals for Alzheimer and Oncology, with Tentative Approval for Gastrointestinal Disease
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
Amneal Pharmaceuticals Gets FDA Approval for Alzheimer's Treatment and Brain Tumor Drug
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...
Amneal gains FDA approval for dementia and oncology drugs
BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX), a pharmaceutical company with a market capitalization of ...
Healthline22d
How Multiple Sclerosis Can Affect Your Speech
Many people living with multiple sclerosis (MS) experience speech issues. With MS, you can develop persistent speech difficulties, or you might have speech problems that come and go. You may find ...